To Determine Maximum Tolerated Dose of BAY79-4620 in Patients With Advanced Solid Tumors

NCT01028755 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer